
RXST vs EYE
$RXST vs $EYE head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
RXST vs EYE: the quick read
- ·EYE is the larger company by market cap ($1.33B vs $216M).
- ·EYE has been more active on our scanner (94 vs 44 alerts in 30 days).
- ·RXST has the smaller float (37.4M vs 77.2M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Ophthalmic Goods vs OPHTHALMIC GOODS), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 94 and 44 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·EYE is the one in play today, trading about 2.2x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing RXST and EYE on TheDesperateTrader.
- Is RXST or EYE the better stock?
- "Better" depends on your goal, and these two are not alike. EYE is the larger company by market cap ($1.33B vs $216M). EYE has been more active on our scanner (94 vs 44 alerts in 30 days). RXST has the smaller float (37.4M vs 77.2M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between RXST and EYE?
- The differences that matter: they are not in the same business - RXST is ophthalmic goods and EYE is ophthalmic goods; EYE is roughly 6x the size of the other by market cap ($216M vs $1.33B); they trade at very different share prices ($5.17 vs $16.88); RXST sits at 8% of its 52-week range against 14% for EYE; our scanner flagged RXST 44 times in the last 30 days against 94 for EYE. Everything above is measured from the latest completed session and SEC filings.
- Which of RXST and EYE is more active right now?
- Right now RXST is at about 1.3x its normal volume and EYE is at about 2.2x, so EYE is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading RXST or EYE? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore RXST and EYE comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.